Identifying Pathways of Physiological Deterioration to Understand Racial Disparities in Cognitive Status: A 4‐way Mediation‐Interaction Decomposition Analysis. (20th December 2022)

• Record Type: Journal Article
• Authors: Higgins, Cesar; Ware, Erin B; Hicken, Margaret; Zawistowski, Matthew; Kobayashi, Lindsay C; Muhkerjee, Bhramar; Bakulski, Kelly M
• Is Part Of: Alzheimer's & dementia. Volume 18(2022)Supplement 11
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-20
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.066210
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: Exposure to interpersonal and structural racism may increase the risk of adverse cognitive aging in racialized groups. Physiological deterioration may lie on the causal pathway leading racism to cognitive aging, but this potential mediating role has never been investigated. We quantified the extent to which the racial disparity (a proxy measure of exposure to racism) in cognitive status was mediated through physiological biomarkers of inflammation, glucose homeostasis, cholesterol ratios, and renal functioning. Methods: Data were from the US Health and Retirement Study in 2006 and 2008. We performed cross‐sectional (n = 9, 107) and 2‐year follow‐up analyses (n = 6, 147) to explore the mediating roles of four physiological biomarkers in racial/ethnic disparities in prevalent and incident dementia. We used self‐reported race/ethnicity as a proxy for exposure to structural and interpersonal forms of racism. Mediators were serum biomarkers of systemic inflammation (hsCRP), glucose homeostasis (HbA1C), cholesterol processing and atherosclerosis risk (TC/HDL‐C ratio), and renal functioning (cystatin C). We performed a 4‐way decomposition analysis that accommodated exposure‐mediator interactions to identify natural direct and indirect effects. Results: In this sample, the prevalence of dementia was 2.2% among non‐Hispanic White, 8.5% among non‐Hispanic Black, and 6.0% among Hispanic participants. Among non‐Hispanic Black relative to non‐Hispanic White participants, the mediating effect of HbA1C on prevalent dementia was 6% (95% CI: ‐4%, 16%) and the interaction effect with race was 11% (95% CI: ‐11%, 34%) (Table 1 ). Similarly, we estimated a mediating effect of cystatin C on prevalent dementia of 0% (95% CI: ‐2%, 2%) and an interaction effect with race of 10% (95% CI: ‐5%, 25%). For incident dementia, among non‐Hispanic Black relative to non‐Hispanic White participants, the mediating effect of hsCRP on incident dementia was 18% (95% CI: ‐6%, 41%), and the interaction effect with race was 45% (95% CI: ‐20%, 110%) (Table 2 ). Results were similar for Hispanic relative to non‐Hispanic White participants. Conclusions: The relationships between race/ethnicity and prevalent and incident dementia were not mediated by or interacted with serum biomarkers of physiological deterioration. Racial disparities in cognitive status in mid‐to‐later life may be attributable to structural factors to racism and the mediating effects of other biomarkers.